P51788 (CLCN2_HUMAN) Homo sapiens (Human)
Chloride channel protein 2 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
8 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Cryo-EM structure of the human CLC-2 chloride channel transmembrane domain with symmetric C-terminal | homo-2-mer | 2×CL; | ||||
Assess | ||||||
Title: Cryo-EM structure of the human CLC-2 chloride channel transmembrane domain with asymmetric C… | homo-2-mer | |||||
Assess | ||||||
Full length human CLC-2 channel in apo state | homo-2-mer | |||||
Assess | ||||||
Cryo-EM structure of the human CLC-2 chloride channel transmembrane domain Apo state with resolved … | homo-2-mer | 2×CL; | ||||
Assess | ||||||
Cryo-EM structure of the human CLC-2 chloride channel transmembrane domain with bound inhibitor AK-… | homo-2-mer | 2×GH6; 2×CL; | ||||
Assess | ||||||
TMD masked refine map of human ClC-2 | homo-2-mer | |||||
Assess | ||||||
AK-42 inhibitor binding human ClC-2 TMD | homo-2-mer | 2×GH6; | ||||
Assess | ||||||
Cryo-EM structure of the human CLC-2 chloride channel C-terminal domain | homo-2-mer | |||||
Assess |
2 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
8ta5.1.A | homo-2-mer | 0.66 | 100.00 | |||
Assess | ||||||
7xf5.1.A | homo-2-mer | 0.65 | 100.00 | |||
Assess |
6 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 8gqu.1.B | monomer | 0.63 | 76.99 | ||
Assess | ||||||
Isoform 3 | 8ta5.1.A | homo-2-mer | 0.65 | 99.09 | ||
Assess | ||||||
Isoform 3 | 7xf5.1.A | homo-2-mer | 0.65 | 99.09 | ||
Assess | ||||||
Isoform 4 | 8ta5.1.A | homo-2-mer | 0.65 | 100.00 | ||
Assess | ||||||
Isoform 4 | 7xf5.1.A | homo-2-mer | 0.64 | 100.00 | ||
Assess | ||||||
Isoform 5 | 7xf5.1.A | homo-2-mer | 0.65 | 100.00 | ||
Assess |